Ester-modified 99mTcO[SN(R)S/S] mixed ligand complexes: Synthesis and preliminary evaluation

Nuclear Medicine and Biology

Volumn 28, Issue 8, 2001, Pages 975-982

  Tsoukalas, C H ^a   Pirmettis, I ^a   Patsis, G ^a   Papadopoulos, A ^a   Raptopoulou, C P ^b   Terzis, A ^b   Papadopoulos, M ^a   Chiotellis, E ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b INSTITUTE OF MATERIALS SCIENCE   (Greece)

Author keywords

Brain Imaging; Mixed ligand complexes; Rhenium; Technetium

Indexed keywords

ESTER; RHENIUM COMPLEX; TECHNETIUM 99M; TECHNETIUM COMPLEX; TECHNETIUM DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SCREENING; DRUG SYNTHESIS; DRUG UPTAKE; HYDROLYSIS; MOUSE; NONHUMAN; TISSUE DISTRIBUTION; ANIMAL; BRAIN; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; BRAIN; ESTERS; MICE; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION;

EID: 0034746804     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(01)00249-9     Document Type: Article

References (29)

1. Formulation of a single-component kit for the preparation of technetium-99m labeled ethyl cysteinate dimer: Biological and clinical evaluation
2. Preparation and absorption spectra of p-mercaptocinnamic and p-mercaptobenzoic acids and derivatives
3. Complex compounds of tertiary phosphines and a tertiary arsine of rhenium (V), rhenium (III) and rhenium (II)
4. 2+ core
5. 99mTc, preliminary distribution studies in animals
6. ′3+1′ Mixed-ligand oxotechnetium (V) complexes with affinity for melanoma: Synthesis and evaluation in vitro and in vivo
7. 99mTc-bicisate (ECD, Neurolite) measured by SPECT on the same day
8. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans
9. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain imaging agents
10. Tc-99m-labeled tropanes as dopamine transporter imaging agents
11. Cerebral perfusion imaging tracers for SPECT: Which one to choose?
12. Syn-Anti isomerism in a mixed-ligand oxorhenium complex ReO[SN(R)S][S]
13. Synthesis, structure, lipophilicity and protonation behavior of mixed ligand rhenium chelates functionalized by amine groups
14. Study on the formation of mixed ligand oxorhenium and oxotechnetium complexes (SNS/S combination)
15. Discrepancies between HMPAO and ECD SPECT imaging in brain tumors
16. Synthesis, characterization and biodistribution in mice of oxotechnetium(V) (SNS/S) mixed ligand complexes with N, N-bis(2-mercaptoethyl)(2-piperidin-1-ylethyl)amine as tridentate ligand
17. 2A receptor
18. Synthesis and characterization of oxotechnetium(V) mixed-ligand complexes containing a tridentate N-substituted bis-(2-mercaptoethyl)amine and a monodentate thiol
19. 99mTc aminobisthiolato/monothiolato “3+1” mixed ligand complexes: Structure-activity and preliminary in vivo validation as brain blood flow imaging agents
20. Lipophilic technetium complexes-VIII. Preparation and animal studies of oxotechnetium(V) complexes with tridentate/monodentate ligand coordination
21. The “n+1” mixed ligand approach in the design of specific technetium radiopharmaceuticals: Potentials and problems
22. Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents
23. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases, comparison with other cerebral perfusion tracers and PET
24. 99mTc-ECD)
25. 99mTc-ECD)
26. Neuropharmacological characterization of Tc99m ECD in human and non-human primates
27. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m-ECD in nonhuman primates